Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
SenesTech, Inc. (SNES)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
8-K
| Quarterly results |
| 11/10/2021 |
8-K
| Quarterly results|
Docs:
|
"SenesTech Announces 2021 Third Quarter Financial and Operational Results Revenue More Than Doubles from the Third Quarter in 2020 and up 14% Sequentially PHOENIX, Ariz., November 10, 2021 SenesTech, Inc. , the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest, announced today revenues for the third quarter of 2021 more than doubled compared to the same period a year ago, and are up 14% sequentially. Year-to-date nine-month revenues were also more than double the same period last year. The record quarterly and year-to-date results are being driven by growth in each of the Company’ s targeted market verticals of agribusiness, municipalities, zoos and sanctuaries, commercial applications, and direct to consumer. The Company has r..." |
|
| 08/12/2021 |
8-K
| Quarterly results|
Docs:
|
"SenesTech Announces 2021 Second Quarter Financial and Operational Results Revenue Growth of 125% from the Second Quarter in 2020 and 82% Sequentially PHOENIX, Ariz., August XX, 2021 SenesTech, Inc. , the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year. The growth is driven by continued adoption of ContraPest across its key market segments and continued strong growth in California, which recently enacted legislation restricting the use of the four major second generation anticoagulant rodenticides , creating market opport..." |
|
| 05/13/2021 |
8-K
| Quarterly results |
| 03/25/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Quarterly results |
| 08/12/2020 |
8-K
| Quarterly results |
| 05/15/2020 |
8-K
| Quarterly results |
| 03/16/2020 |
8-K
| Quarterly results |
| 11/12/2019 |
8-K
| Quarterly results |
| 08/13/2019 |
8-K
| Quarterly results|
Docs:
|
"SenesTech Announces Second Quarter 2019 Financial and Operational Results FLAGSTAFF, Ariz., August 13, 2019 -- SenesTech, Inc. , a developer of proprietary technologies for managing animal pest populations through fertility control, today announced financial and operational results for the second quarter of fiscal 2019, which ended June 30, 2019. “Since taking over as CEO three months ago, we have made a number of significant changes in our go forward strategy intended to drive commercial adoption of our highly disruptive technology,” commented Ken Siegel, Chief Executive Officer of SenesTech. “Specifically, we have narrowed our focus to key market verticals and geographies that we believe are most likely to generate near term results, focusing in on zoos and sanctuaries, municipalities an..." |
|
| 05/15/2019 |
8-K
| Quarterly results |
| 03/28/2019 |
8-K
| Quarterly results |
| 11/13/2018 |
8-K
| Quarterly results |
| 08/13/2018 |
8-K
| Quarterly results |
| 05/14/2018 |
8-K
| Quarterly results |
| 04/04/2018 |
8-K
| Quarterly results |
| 05/11/2017 |
8-K
| Quarterly results |
| 03/30/2017 |
8-K
| Form 8-K - Current report |
|
|